IRS1 and Insulin resistance: In PCOS, PTM-mediated signaling perturbations are central to drive key pathological features, such as insulin resistance [11]; hyperphosphorylation of IRS-1 impairs PI3K/Akt signaling, inducing GC insulin resistance [12].